相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。PD-1+ immune cell infiltration inversely correlates with survival of operable breast cancer patients
Shenyou Sun et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2014)
Tumor-specific CD4+ T cells maintain effector and memory tumor-specific CD8+ T cells
Sarah E. Church et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2014)
PD-L1 Expression Is Increased in a Subset of Basal Type Breast Cancer Cells
Hatem Soliman et al.
PLOS ONE (2014)
Tumour-infiltrating CD8+lymphocytes as an independent predictive factor for pathological complete response to primary systemic therapy in breast cancer
A. N. Seo et al.
BRITISH JOURNAL OF CANCER (2013)
Myeloid leukemia cells with a B7-2+ subpopulation provoke Th-cell responses and become immuno-suppressive through the modulation of B7 ligands
Yusuf Dolen et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2013)
Neutralizing Tumor-Promoting Chronic Inflammation: A Magic Bullet?
Lisa M. Coussens et al.
SCIENCE (2013)
Up-Regulation of PD-L1, IDO, and Tregs in the Melanoma Tumor Microenvironment Is Driven by CD8+ T Cells
Stefani Spranger et al.
SCIENCE TRANSLATIONAL MEDICINE (2013)
Expanding roles for CD4T cells and their subpopulations in tumor immunity and therapy
Mark J. Dobrzanski
FRONTIERS IN ONCOLOGY (2013)
Differential pattern and prognostic significance of CD4+, FOXP3+ and IL-17+ tumor infiltrating lymphocytes in ductal and lobular breast cancers
Raoul Droeser et al.
BMC CANCER (2012)
The relationship between components of tumour inflammatory cell infiltrate and clinicopathological factors and survival in patients with primary operable invasive ductal breast cancer
Z. M. A. Mohammed et al.
BRITISH JOURNAL OF CANCER (2012)
Basal-like Breast Cancer Cells Induce Phenotypic and Genomic Changes in Macrophages
Delisha A. Stewart et al.
MOLECULAR CANCER RESEARCH (2012)
Safety and Activity of Anti-PD-L1 Antibody in Patients with Advanced Cancer
Julie R. Brahmer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Safety, Activity, and Immune Correlates of Anti-PD-1 Antibody in Cancer
Suzanne L. Topalian et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Colocalization of Inflammatory Response with B7-H1 Expression in Human Melanocytic Lesions Supports an Adaptive Resistance Mechanism of Immune Escape
Janis M. Taube et al.
SCIENCE TRANSLATIONAL MEDICINE (2012)
CD8(+) lymphocyte infiltration is an independent favorable prognostic indicator in basal-like breast cancer
Shuzhen Liu et al.
BREAST CANCER RESEARCH (2012)
CD8+ cytotoxic T cell and FOXP3+ regulatory T cell infiltration in relation to breast cancer survival and molecular subtypes
Fangfang Liu et al.
BREAST CANCER RESEARCH AND TREATMENT (2011)
Enrichment of CCR6(+)Foxp3(+) regulatory T cells in the tumor mass correlates with impaired CD8(+) T cell function and poor prognosis of breast cancer
Lin Xu et al.
CLINICAL IMMUNOLOGY (2010)
Immune Compartmentalization of T cell Subsets in Chemically-induced Breast Cancer
T. Fahmi et al.
SCANDINAVIAN JOURNAL OF IMMUNOLOGY (2010)
Regulatory T Cells Recruited through CCL22/CCR4 Are Selectively Activated in Lymphoid Infiltrates Surrounding Primary Breast Tumors and Lead to an Adverse Clinical Outcome
Michael Gobert et al.
CANCER RESEARCH (2009)
PD-L1 regulates the development, maintenance, and function of induced regulatory T cells
Loise M. Francisco et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2009)
Molecular Profiling of Breast Cancer Cell Lines Defines Relevant Tumor Models and Provides a Resource for Cancer Gene Discovery
Jessica Kao et al.
PLOS ONE (2009)
Triple-negative/basal-like breast cancer: review
Emad A. Rakha et al.
PATHOLOGY (2009)
PD-1 and its ligands in tolerance and immunity
Mary E. Keir et al.
ANNUAL REVIEW OF IMMUNOLOGY (2008)
Clinical significance of tumor-infiltrating lymphocytes in neoplastic progression and lymph node metastasis of human breast cancer
Bor-Ching Sheu et al.
BREAST (2008)
Expression of B7-H1 in breast cancer patients is strongly associated with high proliferative Ki-67-expressing tumor cells
Hazem Ghebeh et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
Cancer despite immunosurveillance: immunoselection and immunosubversion
Laurence Zitvogel et al.
NATURE REVIEWS IMMUNOLOGY (2006)
The B7-H1 (PD-L1) T lymphocyte-inhibitory molecule is expressed in breast cancer patients with infiltrating ductal carcinoma: Correlation with important high-risk prognostic factors
Hazem Ghebeh et al.
NEOPLASIA (2006)
Cutting edge:: Murine vascular endothelium activates and induces the generation of allogeneic CD4+25+Foxp3+ regulatory T cells
AS Krupnick et al.
JOURNAL OF IMMUNOLOGY (2005)
Type 1 and type 2 tumor infiltrating effector cell subpopulations in progressive breast cancer
JB Reome et al.
CLINICAL IMMUNOLOGY (2004)
The immunophenotype and activation status of the lymphocytic infiltrate in human breast cancers, the role of the major his to compatibility complex in cell-mediated immune mechanisms, and their association with prognostic indicators
SN Georgiannos et al.
SURGERY (2003)
A new mathematical model for relative quantification in real-time RT-PCR
MW Pfaffl
NUCLEIC ACIDS RESEARCH (2001)
IFNγ and lymphocytes prevent primary tumour development and shape tumour immunogenicity
V Shankaran et al.
NATURE (2001)
分享论文
